The estimated Net Worth of W Richard Staub is at least $9.92 million dollars as of 29 February 2024. Mr. Staub owns over 14,100 units of IQVIA Inc stock worth over $3,783,749 and over the last 8 years he sold IQV stock worth over $3,493,980. In addition, he makes $2,641,160 as President - Research and Development Solutions at IQVIA Inc.
Sign up
Mr. Staub IQV stock SEC Form 4 insiders trading
Walter has made over 4 trades of the IQVIA Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 14,100 units of IQV stock worth $3,493,980 on 29 February 2024.
The largest trade he's ever made was exercising 33,890 units of IQVIA Inc stock on 7 August 2020 worth over $2,955,208. On average, Walter trades about 4,842 units every 92 days since 2017. As of 29 February 2024 he still owns at least 15,945 units of IQVIA Inc stock.
You can see the complete history of Mr. Staub stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Walter Staub biography
Walter Richard Staub III serves as President - Research and Development Solutions of the Company. Mr. Staub served as President of Novella Clinical, a Quintiles company, since 2013. Prior to Novella’s 2013 acquisition by Quintiles, Mr. Staub served as both president and CEO of Novella Clinical since 2008. Before joining Novella Clinical in 2004, Mr. Staub was senior vice president of global business development for one of the world’s largest clinical research organizations. Mr. Staub’s career in the pharmaceutical industry began at Zeneca Pharmaceuticals in 1989 where he had progressive responsibilities as a medical and hospital sales representative, cardiovascular portfolio analyst and marketing manager. Mr. Staub has a Bachelor of Arts degree in Economics from the University of North Carolina at Chapel Hill.
What is the salary of Walter Staub?
As the President - Research and Development Solutions of IQVIA Inc, the total compensation of Walter Staub at IQVIA Inc is $2,641,160. There are 2 executives at IQVIA Inc getting paid more, with Ari Bousbib having the highest compensation of $22,139,800.
How old is Walter Staub?
Walter Staub is 57, he's been the President - Research and Development Solutions of IQVIA Inc since 2016. There are 11 older and 6 younger executives at IQVIA Inc. The oldest executive at IQVIA Holdings Inc is Ronald Rittenmeyer, 72, who is the Independent Director.
What's Walter Staub's mailing address?
W's mailing address filed with the SEC is C/O IQVIA HOLDINGS INC., 2400 ELLIS ROAD, DURHAM, NC, 27703.
Insiders trading at IQVIA Inc
Over the last 7 years, insiders at IQVIA Inc have traded over $7,012,312,980 worth of IQVIA Inc stock and bought 83,468 units worth $15,560,595 . The most active insiders traders include John Connaughton, Pension Plan Investment Boa... et Group Holdings (Sbs) Adviso.... On average, IQVIA Inc executives and independent directors trade stock every 29 days with the average trade being worth of $160,151,634. The most recent stock trade was executed by Eric Sherbet on 27 August 2024, trading 1,300 units of IQV stock currently worth $320,229.
What does IQVIA Inc do?
quintiles and imshealth have merged together to form the new quintilesims. each wanting to bring something new to customers, we deliver integrated information and technology solutions to drive healthcare forward. quintilesims has approximately 50,000 employees conducting operations in more than 100 countries, dedicated to helping our clients improve their clinical, scientific and commercial results. as a global leader in protecting individual patient privacy, quintilesims uses healthcare data to deliver critical, real-world disease and treatment insights. to learn more, visit www.quintilesims.com
What does IQVIA Inc's logo look like?
Complete history of Mr. Staub stock trades at IQVIA Inc
IQVIA Inc executives and stock owners
IQVIA Inc executives and other stock owners filed with the SEC include:
-
Ari Bousbib,
Chairman of the Board, President, Chief Executive Officer -
Ari Bousbib,
Chairman, Pres & CEO -
Walter Staub,
President - Research and Development Solutions -
Kevin Knightly,
President - Information and Technology Solutions -
Eric Sherbet,
Executive Vice President, General Counsel, Secretary -
Ronald E. Bruehlman,
Exec. VP & CFO -
W. Richard Staub III,
Pres of R&D Solutions -
Eric M. Sherbet,
Exec. VP, Gen. Counsel & Sec. -
Kevin C. Knightly,
Pres of Technology & Commercial Solutions -
John Leonard,
Lead Independent Director -
Ronald Rittenmeyer,
Independent Director -
Colleen Goggins,
Independent Director -
John Danhakl,
Independent Director -
Carol Burt,
Independent Director -
Ronald Bruehlman,
Interim Chief Financial Officer, Executive Vice President -
Todd Sisitsky,
Independent Director -
James Fasano,
Independent Director -
John Connaughton,
Independent Director -
Trudy Stein,
Chief HR Officer & Exec. VP -
Nicholas Childs,
Sr. VP, Investor Relations & Corp. Communications -
Andrew Markwick,
Sr. VP of Investor Relations & Treasury -
Alejandro Martinez,
Chief Information Officer -
Dr. Jeffrey A. Spaeder,
Sr. VP, Global Chief Medical & Scientific Officer -
Emmanuel N. Korakis,
Sr. VP, Corp. Controller & Principal Accounting Officer -
Michael R Mcdonnell,
EVP and CFO -
W Richard Staub,
See Remarks -
Group Holdings (Sbs) Adviso...,
-
Investment Board Private Ho...,
-
Robert Parks,
Sr Vice President, Controller -
Michael J Evanisko,
Director -
Jack M Greenberg,
Director -
Iii James H Erlinger,
See Remarks -
Pension Plan Investment Boa...,
10% owner -
Pension Plan Investment Boa...,
-
Emmanuel N Korakis,
See Remarks -
Morris Leslie Wims,
Director -
Sheila A Stamps,
Director -
Bhavik Patel,
See Remarks -
Keriann Cherofsky,
See Remarks -
Constantinos Panagos,
See Remarks -
Jim Fasano,
Director